Hormone Replacement Therapy Research Today is a free monthly online journal that collates and summarizes the latest research about Hormone Replacement Therapy, including details on hrt, menopause, natural hrt, effects, risks.

Volume 2 (2005), Issue 3 (March)

1. Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women.
   Biol Psychol, 69(1): 39-56. [Abstract] [Full-text]
2. Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis.
   Fertil Steril, 83(3): 558-66. [Abstract] [Full-text]
3. Increased levels of serum osteoprotegerin in hypothyroid patients and its normalization with restoration of normal thyroid function.
   Eur J Endocrinol, 152(3): 347-53. [Abstract] [Full-text]
4. Comparison of hormone levels in nipple aspirate fluid of pre- and postmenopausal women: effect of oral contraceptives and hormone replacement.
   J Clin Endocrinol Metab, 90(3): 1686-91. [Abstract] [Full-text]
5. The rise and fall of menopausal hormone therapy.
   Annu Rev Public Health, 26: 115-40. [Abstract] [Full-text]
6. Identifying target regions for vigilance improvement under hormone replacement therapy in postmenopausal syndrome patients by means of electroencephalographic tomography (LORETA).
   Psychopharmacology (Berl), 178(4): 389-99. [Abstract] [Full-text]
7. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval.
   Acta Obstet Gynecol Scand, 84(4): 395-401. [Abstract] [Full-text]
8. Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
   Arch Intern Med, 165(5): 510-5. [Abstract] [Full-text]
9. Postmenopausal hormone replacement therapy increases plasmatic thromboxane beta 2.
   Int J Cardiol, 99(3): 449-54. [Abstract] [Full-text]
10. Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies.
    J Obstet Gynaecol Res, 31(2): 107-14. [Abstract] [Full-text]
11. Relationship of physical fitness, hormone replacement therapy, and hemostatic risk factors in postmenopausal women.
    J Appl Physiol, 98(4): 1341-8. [Abstract] [Full-text]
12. The effect of hormone replacement therapy and simvastatin on plasma homocysteine.
    J Womens Health (Larchmt), 14(2): 154-8. [Abstract] [Full-text]
13. Insulin sensitivity in women with coronary heart disease during hormone replacement therapy.
    J Womens Health (Larchmt), 14(2): 137-45. [Abstract] [Full-text]
14. Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study.
    BJOG, 112(4): 476-85. [Abstract] [Full-text]
15. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.
    Osteoporos Int, 16(4): 372-9. [Abstract] [Full-text]
16. Intranasal 17beta-estradiol treatment and Vitamin B12, folate and homocysteine in menopause.
    Maturitas, 50(4): 353-8. [Abstract] [Full-text]
17. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
    Maturitas, 50(4): 344-52. [Abstract] [Full-text]
18. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Maturitas, 50(4): 321-30. [Abstract] [Full-text]
19. Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women.
    Maturitas, 50(4): 312-20. [Abstract] [Full-text]
20. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
    Maturitas, 50(4): 305-11. [Abstract] [Full-text]
21. Long-term treatment with vaginal estradiol tablets--an impact on uterine artery blood flow.
    Maturitas, 50(4): 300-4. [Abstract] [Full-text]
22. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Maturitas, 50(4): 289-93. [Abstract] [Full-text]
23. Early impact of hormone replacement therapy on vascular hemodynamics detected via ocular colour Doppler analysis.
    Maturitas, 50(4): 282-8. [Abstract] [Full-text]
24. Effects in post-menopausal women of transdermal estrogen associated with progestin upon the removal from the plasma of a microemulsion that resembles low-density lipoprotein (LDL).
    Maturitas, 50(4): 275-81. [Abstract] [Full-text]
25. Acute administration of 17beta-estradiol improves endothelium-dependent vasodilation in postmenopausal women.
    Maturitas, 50(4): 266-74. [Abstract] [Full-text]
26. Vascular reactivity and atheromatous plaques in post-menopausal women on tibolone treatment. Open prospective study with Doppler ultrasonography in internal carotid artery.
    Maturitas, 50(4): 259-65. [Abstract] [Full-text]
27. Differential estrogen signaling in endothelial cells upon pulsed or continuous administration.
    Maturitas, 50(4): 247-58. [Abstract] [Full-text]
28. Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.
    Maturitas, 50(4): 239-46. [Abstract] [Full-text]
29. Estradiol induced inhibition of 11beta-hydroxysteroid dehydrogenase 1: an explanation for the postmenopausal hormone replacement therapy effects.
    Med Hypotheses, 64(5): 989-91. [Abstract] [Full-text]
30. Catamenial pneumothorax: optimal hormonal and surgical management.
    Eur J Cardiothorac Surg, 27(4): 662-6. [Abstract] [Full-text]
31. Estrogen modulates cognitive and cholinergic processes in surgically menopausal monkeys.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(3): 423-31. [Abstract] [Full-text]
32. Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging--initial observations.
    Radiology, 235(1): 36-41. [Abstract] [Full-text]

© 2004-2008 Hormone Replacement Therapy Research Today. All Rights Reserved.